Altamira Therapeutics Ltd. - CYTOF

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q3 2022 · Q2 2022
Value (USD)
Total reported value ($000)
$81K
QoQ value delta ($000)
-$37K (-31.36%)
Implied price effect (QoQ)
-40.67%
Shares
Total shares
282,944
QoQ shares delta
+38,391 (+15.7%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CYTOF)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q3 2022)

Top 25 only Full list
Early Q3 2023 data: only 7 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
CITADEL ADVISORS LLC 30 104,120 0.0%
GROUP ONE TRADING, L.P. 19 64,776 0.0%
MORGAN STANLEY 17 58,731 0.0%
RENAISSANCE TECHNOLOGIES LLC 6 19,946 0.0%
GEODE CAPITAL MANAGEMENT, LLC 5 18,871 0.0%
SIMPLEX TRADING, LLC 2 7,552 0.0%
UBS Group AG 2 8,133 0.0%
BANK OF AMERICA CORP /DE/ 0 5 0.0%
WELLS FARGO & COMPANY/MN 0 500 0.0%
ADVISOR GROUP HOLDINGS, INC. 0 310 0.0%